Canakinumab for Atherosclerotic Disease
N Engl J Med
.
2018 Jan 11;378(2):199.
doi: 10.1056/NEJMc1714635.
Authors
Nitesh Nerlekar
1
,
Richard W Harper
1
Affiliation
1
Monash University, Melbourne, VIC, Australia nitesh.nerlekar@monash.edu
PMID:
29322758
DOI:
10.1056/NEJMc1714635
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal*
Antibodies, Monoclonal, Humanized
Atherosclerosis*
Humans
Substances
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
canakinumab
Grants and funding
109443/Z/15/Z/WT_/Wellcome Trust/United Kingdom